Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment

Title
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
Authors
Keywords
Ewing sarcoma, oncolytic herpes virus, tumor-associated macrophage, pediatric sarcoma, immunotherapy, trabectedin, myeloid-derived suppressor cells
Journal
Molecular Therapy-Oncolytics
Volume 11, Issue -, Pages 62-74
Publisher
Elsevier BV
Online
2018-10-19
DOI
10.1016/j.omto.2018.10.001

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started